CRITERIA AND CLASSIFICATION Flashcards

1
Q

Diagnostic Criteria for Classical Sweet Syndrome versus Drug-Induced Sweet Syndrome

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Algorithm for the Diagnosis of Patch-Stage Mycosis Fungoides (4 Points Are Required)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Revised Diagnostic Criteria for Hypereosinophilic Syndromes

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnostic Criteria for Systemic Mastocytosis (Major and One Minor or Three Minor Criteria Are Needed)a

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SCORTEN: A Prognostic Scoring System for Patients with Epidermal Necrolysis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diagnostic Criteria for Epidermolysis Bullosa Acquisita

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The 1982 Revised Criteria for Classification of Systemic Lupus Erythematosusa

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sontheimerโ€™s Proposed Diagnostic Criteria for Cutaneous Dermatomyositis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The Classification Criteria for PsA (CASPAR)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

2010 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Arthritis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Adult-Onset Still Disease Criteria

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diagnosis of Acute Rheumatic Fever in Patient Populations with Evidence of Preceding Group A Streptococcal Infection Using the 2015 Revised Jones Criteria

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Proposed Classification Criteria for Sjรถgren Syndrome

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Revised International Classification Criteria for Sjรถgren Syndrome

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Relapsing polychondritis diagnostic criteria

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Classical EDS (cEDS)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Criteria for Skin Hyperextensibility

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Beighton Criteria for Joint Hypermobility

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Criteria for Diagnosis of Waardenburg Syndrome

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Subtypes of Rosacea

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Classification of Rosacea from 2016 and 2017: Diagnostic, Major, and Secondary Features of Rosacea

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Classification of Rhinophymata

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Classification of Ocular Rosacea

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Primary Focal (Essential) Hyperhidrosis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Hyperhidrosis Disease Severity Scale

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Treatment Options for Primary Focal Hyperhidrosis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Hidradenitis Suppurativa

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Hurley Staging of hidradenitis suppurativa

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Prognostic Signs of Frostbite

A
30
Q

Clinical Manifestations of Burn Injury Are Determined by Depth and Breadth of Tissue Destruction

A
31
Q

Parkland Formula for Fluid Administration in the First 24 Hours

A
32
Q

Congenital lumbosacral midline skin lesions, required assessment, and risk of occult spinal dysraphism

A
33
Q

Classification of Cutaneous Appendage Tumors

A
34
Q

Classification of Actinic Keratosis

A
35
Q

Common Basal Cell Carcinoma Subtypes with Corresponding Kodachrome

A
36
Q

Diagnostic Criteria for Basal Cell Nevus Syndrome (BCNS, Gorlin Syndrome)

A
37
Q

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelinesยฎ): Risk Factors for Local Recurrence or Metastases

A
38
Q

Clinical Features of Merkel Cell Carcinoma

A
39
Q

When to Consider Malignancy in Pigmented Nail Lesions

A
40
Q

ABCDE Checklist of Melanoma

A
41
Q

Melanoma TNM Classifications

A
42
Q

Stage Groupings for Cutaneous Melanoma

A
42
Q

Treatment algorithm of Melanoma

A
43
Q

Clinical spectrum of LCH

A
44
Q

PHACE Diagnostic Criteria

A
45
Q

Cutaneous lymphomas

A
46
Q

Algorithm for Diagnosis of Early Mycosis Fungoides

A
47
Q

Spectrum of Cutaneous Pseudolymphoma

A
48
Q

Diagnostic Criteria for Hereditary Leiomyomatosis and Renal Cell Carcinoma

A
49
Q

Histologic Criteria for the Definition of Amyloid

A
50
Q

Classification of Hyperuricemia

A
51
Q

Revised classification of acute and chronic GVHD

A
52
Q

Acute Graft-Versus-Host Disease Staging

A
53
Q

Clinical Features of Chronic Graft-Versus-Host Disease

A
54
Q

Diagnostic Criteria for Neurofibromatosis Type 1

A
55
Q

Diagnostic Criteria for Neurofibromatosis Type 2

A
56
Q

Diagnostic Criteria for Tuberous Sclerosis Complex (Updated at 2012 Conference)

A
57
Q

Definition of the Metabolic Syndrome (Any 3 of 5 Traits)

A
58
Q

International Criteria for Behรงet Disease

A
59
Q

Diagnostic Criteria for Classic Kawasaki Disease

A
60
Q

Criteria for Diagnosis of Incomplete Kawasaki Disease

A
61
Q

Criteria for Primary Raynaud Phenomenon

A
62
Q

Acute Limb Ischemia: 6 Ps

A
63
Q

Classification of Infectious Folliculitis

A
64
Q

ALT-70 Risk Prediction for Cellulitis

A
65
Q

Indications for Parenteral Administration of Antibiotics

A
66
Q

Centers for Disease Control and Prevention 2011 Case Definition of Staphylococcal Toxic Shock Syndrome

A
67
Q

Proposed Cutaneous Variants of Necrotizing Fasciitis

A
68
Q

Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) Score

A
69
Q

Factors Found in Literature to Be Associated with a High Mortality Risk in Patients with Necrotizing Fasciitis

A
70
Q

Modified Duke Criteria for Infective Endocarditis

A
71
Q

Classification of Cutaneous Tuberculosis

A